Tag Archives: Healthcare

Gesundheit/Medizin

Animal Models to Gain Ground in Light of their Efficacy in Testing of Vaccines & Therapies for Viral Epidemics, unveils Fact.MR

With the rapid developments in the healthcare industry to arrest the prevalence of chronic diseases, there is an ever-increasing need for conducting the best medicines and drugs. This is expected to be a key growth influencer of the animal model market. Use of animal model in biomedical research has a rapid development in the development of new methods of treatment for new and chronic diseases, and understands the potential of drugs with regard to pervasive diseases.

A recent report compiled by Fact.MR projects the animal model market to register an impressive CAGR of over 6.0% during the period of forecast, 2017 to 2026 . The healthcare sector is seen harnessing animal models, owing to which the demand for animal model is surging in the healthcare sector. The animal model is expected to outpace its alternative search as workers cultures and computer models.

Request For Sample Report – https://www.factmr.com/connectus/sample?flag=S&rep_id=1590

Viral epidemics seek as Zika and Ebola, which have significant prevalence in regions such as Africa and Latin America, have placed a significant burden on the healthcare sector. Lack of understanding about host immune factors that has outlined the development of effective treatment or vaccines. Effectiveness of animal models in developing and testing efficacy of vaccines and therapies, prior to their use in human candidates, is likely to augur well for the growth of the animal models market.

North America is expected to remain the largest market for animal models with revenues estimated to be over US $ 800 million. Considering the Asia-Pacific market for animal model, it accounts for a larger revenue share versus the market in Europe. CAGR, as compared to Latin America & Middle East & Africa (MEA) through 2026.

CAGR by the end of 2026. The largest share is contributed by Asia-Pacific region in rats market. However, dogs and pigs remain the least profitable species segments of the animal model market. Between basic and applied research and drug discovery model, the former is expected to register with the CAGR. However, drug discovery / development remains a lucrative application of the animal model.

To Get More Information on Animal Model Market, Visit – https://www.factmr.com/report/1590/animal-model-market

Sensing the surging growth in the application of animal model, key market players are contributing to the increasing implementation of animal model in drug development and research sectors. Eurofins Scientific SE is an analytical testing services provider for evaluating the safety, composition, authenticity, and purity of biological substances and products. Eurofin Advinus Company for the research and development of compounds in pharmaceuticals, biologics, agrochemical, and cosmetics. The company has indulged in mergers and acquisitions of laboratories and research institutes to further flourish their contribution to the growth of the animal model market. Additionally,

The spurring need for animal models, therefore, triggers the constant strategic advancements made by the market players to outgrow the rest, eventually fueling the expansion of the animal model market. Due to the continuing application of biomedical research as well as the increasing application of animal model in academic and research institutions, animal modeling is sure to grow undoubtedly.

To Buy Animal Model Market Report, Visit https://www.factmr.com/checkout/1590/S

About Fact.MR

Fact.MR is a full-growing suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that’s why we publish multi-industry global, regional, and country-specific research reports.

Contact Us

Fact.MR

11140 Rockville Pike

Suite 400

Rockville, MD 20852

United States

Email: sales@factmr.com

Web: https://www.factmr.com/

Gesundheit/Medizin

Coronary Stent Market worth 10.31 Billion USD by 2021

Coronary Stent Market by Type (BMS, BVS, Drug Eluting), Mode of Delivery (Self, Balloon Expandable), Material (Metal (Stainless Steel, CoCr, PtCr, Nitinol), Polymer, Copolymer), & End User (Hospital, Cardiology Center, ASC) – Global Forecasts to 2021

The global Coronary Stent Market is expected to reach USD 10.31 Billion by 2021 from USD 7.16 Billion in 2016, at a CAGR of 7.6% during the forecast period.

The growth of this market is mainly driven by factors such as technological advancements, increasing number of percutaneous coronary intervention (PCI) procedures, rising burden of CAD, increasing demand for minimally invasive procedures, and rising geriatric population. Moreover, development of bioresorbable vascular scaffold (BVS) and expansion in emerging markets provide significant growth opportunities in the market. However, alternative treatment methods for CAD, stringent regulations for product approval, and numerous cases of product failure and product recall may hinder the growth of this market during the forecast period.

Download Brochure: https://www.marketsandmarkets.com/pdfdownload.asp?id=77411272  

The report segments the Coronary Stent Market based on type, mode of delivery, material, end user, and region. Based on type, the market is segmented into bare-metal stents, drug-eluting stents and bioabsorbable stents. The drug-eluting stents segment is expected to account for the largest share of the coronary stents market in 2016. This can primarily be attributed to the advantages of drug-eluting stents over bare-metal stents, such as lower risk of restenosis and other related complications.  Based on mode of delivery, the Coronary Stent Market is segmented into balloon-expandable stents and self-expanding stents. The balloon expandable stents segment is expected to grow at the highest CAGR during the forecast period due to factors such as increasing research activities to improve this technology, high utilization of these stents, and growing regulatory approvals for balloon-expandable stents.

Based on region, the Coronary Stent Market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). In 2016, North America is expected to dominate the market, followed by Europe. Asia is poised to be the fastest-growing region during the forecast period. Factors such as large population base, growing prevalence of cardiac diseases, rising adoption of advanced technologies, and low manufacturing costs in the region are expected to drive market growth in Asia. Moreover, the growing focus of major players in this region is expected to boost the coronary stents market in Asia.

The Coronary Stent Market is a highly fragmented market, with several big and emerging players. Key market players include Medtronic, plc (Ireland), Abbott Laboratories (U.S.), Boston Scientific Corporation (U.S.), Biosensors International Group, Ltd. (Singapore), BIOTRONIK SE & Co. KG (Germany), B. Braun Melsungen AG (Germany), Terumo Corporation (Japan), STENTYS SA (France), MicroPort Scientific Corporation (China), Meril Life Sciences Pvt. Ltd. (India), Vascular Concepts (India), and Translumina GmbH (Germany).

Contact:

Mr. Shelly Singh

MarketsandMarkets™ INC.

630 Dundee Road

Suite 430

Northbrook, IL 60062

USA: 1-888-600-6441
newsletter@marketsandmarkets.com

Gesundheit/Medizin

Structural Heart Devices Market – Growth Factors Forecast To 2023

Structural Heart Devices Market by Product (Heart Valve Devices (Transcatheter and Surgical), Occluders and Delivery Systems, Annuloplasty Rings, and Accessories), Procedure (Replacement and Repair) – Global Forecast to 2023

The global Structural Heart Devices Market is projected to reach USD 15.08 billion by 2023 from USD 9.28 billion in 2018, at a CAGR of 10.2%. Growth in this market is mainly driven by the rising prevalence of structural heart diseases, regulatory approvals for new and advanced structural heart devices, favorable reimbursement scenario for structural heart procedures & devices, and increasing awareness about structural heart diseases. The emergence of tissue engineered heart valves, increased adoption of percutaneous interventions such as TAVR, and emerging economies such as China, India, Brazil, and several Middle Eastern countries are expected to offer further growth opportunities for players operating in the market during the forecast period.

On the basis of product, the Structural Heart Devices Market is segmented into heart valve devices, occluders and delivery systems, annuloplasty rings, other devices, and accessories. The heart valve devices segment is further divided into transcatheter heart valves and surgical heart valves. The heart valve devices segment is expected to account for the largest share of the Structural Heart Devices Market in 2018. The growing number of transcatheter aortic valve replacement procedures performed across the globe, the efficacy and durability of these products, and the growing number of regulatory approvals for heart valve devices are some of the key factors supporting the growth of this product segment.

Download Brochure: https://www.marketsandmarkets.com/pdfdownload.asp?id=161123753

By procedure, the market has been broadly segmented into replacement procedures and repair procedures. Repair procedures are further segmented into closure procedures, annuloplasty, valvuloplasty, and transcatheter mitral valve repair while replacement procedures are further segmented into transcatheter aortic valve replacement (TAVR) and surgical aortic valve replacement (SAVR). The replacement procedures segment is expected to account for the largest share of the Structural Heart Devices Market in 2018. This can be attributed to the long-term durability of these procedures and the widespread preference for transcatheter replacement.

Asia Pacific is expected to register the highest growth rate during the forecast period. The high growth in this region can be attributed to the rising geriatric population, favorable reimbursement scenario, increasing regulatory approvals, the presence of a large target patient population, increasing healthcare expenditure, implementation of government-funded insurance schemes, and the growing medical tourism industry in several APAC countries.

Contact:

Mr. Shelly Singh

MarketsandMarkets™ INC.

630 Dundee Road

Suite 430

Northbrook, IL 60062

USA: 1-888-600-6441
newsletter@marketsandmarkets.com

Pressemitteilungen

Thomas Baptiste wird neues Mitglied im RTI Beirat

Baptiste unterstützt RTI als Simulation-Marktberater

Thomas Baptiste wird neues Mitglied im RTI Beirat

Thomas Baptiste, Präsident und CEO des NCS und neues Mitglied im RTI-Beirat.

Sunnyvale (USA)/München, September 2018 – Real-Time Innovations (RTI) nimmt Generalleutnant Thomas Baptiste als neuestes Mitglied in den RTI-Beirat auf. Als Simulation-Marktberater soll Baptiste RTI dabei unterstützen, das Bewusstsein für die Vorteile zu schärfen, die virtuelles Training und Simulation den militärischen Märkten sowie den IIoT-Märkten bringen können, u. a. Luft- und Raumfahrt und Healthcare.

Baptiste, Präsident und CEO des National Center for Simulation (NCS), gilt als renommierter Simulationsstratege. Als ehemaliger Generalleutnant der United States Air Force besitzt er über 30 Jahre militärische Erfahrung und diente zuletzt als stellvertretender Vorsitzender dem Militärausschuss der North Atlantic Treaty Organization (NATO) in Brüssel, Belgien.

Im NCS bemüht sich Baptiste um ein wachsendes Bewusstsein für Modellierung und Simulation für das Training und weitere Anwendungsbereiche, u. a. Militär, Healthcare, Transportwesen, Bildung und Technologie. Baptiste arbeitet daran, die Simulatoren realistischer, spannender und ansprechender zu gestalten. So werden künftige Simulatoren synthetisches Training mit Live-Training kombinieren und mit den Live-Teilnehmern interagieren.

RTI bietet das ideale Konnektivitäts-Framework für Trainings- und Simulationsanwendungen und hat in diesem Markt ein schnelles Wachstum erfahren. So bewährte sich RTI Connext DDS bereits in zahlreichen Systemdesigns weltweit, u. a. dem National Advanced Driving Simulator, dem U.S. Army Synthetic Training Environment (STE) Program und den AMRDEC-SED System Integration Labs. Ebenso arbeitete RTI mit VT MAK, dem führenden Entwickler von Modellierungs- und Simulationssoftware, zusammen, um die Interoperabilität zwischen HLA Federations und DDS-basierten Systemen zu demonstrieren.

Während der IIoT-Markt weiter expandiert, will RTI die Vorteile der Simulationstechnologie aus der Luft- und Raumfahrt und Verteidigung auch für andere kommerzielle Märkte zugänglich machen.

„Der Simulation-Markt wächst in den Bereichen Luft- und Raumfahrt, Verteidigung, Medizintechnik und vielen weiteren Applikationen exponentiell“, berichtet Stan Schneider, CEO von RTI. „Heute betreibt RTI in diesen Märkten viele reale Systeme. Durch die Integration der Simulation sind wir in einer guten Ausgangslage, um die nächste Generation von kombinierten Simulation- und realen Systemen zu gestalten. Zudem arbeiten wir daran, Cross-Service- und Cross-Alliance-Trainingsmöglichkeiten aufzubauen. Thomas‘ Expertise, seine hervorragenden Verbindungen und sein militärischer Hintergrund sind für unseren Eintritt in den Simulation-Markt von großem Nutzen.“

„Simulatoren haben nicht nur für die militärische Ausbildung großes Potenzial. Die größte Herausforderung besteht jedoch darin, den Simulator realistisch genug zu machen, damit er vom menschlichen Bediener akzeptiert wird“, erklärt Thomas Baptiste, Präsident und CEO des National Center for Simulation und Mitglied im RTI-Beirat. „Wir bemühen uns um die Integration von Live-, virtueller und konstruktiver Simulation und die Technologie von RTI ist dabei eine entscheidende Komponente.“

Im RTI-Beirat lotet Baptiste nun zusammen mit dem Gründungsmitglied Scott McNealy, dem Automobilberater KT Neumann und dem Energieberater Raiford Smith strategische Wachstumschancen aus, um den Einfluss des Unternehmens im IIoT zu vergrößern. Im Laufe des Jahres 2018 will RTI weitere Mitglieder für den Beirat in jedem relevanten IIoT-Marktbereich gewinnen.

Weitere Informationen zum RTI-Beirat gibt es hier: https://bit.ly/2Ktygj8

Real-Time Innovations (RTI) bietet die Konnektivitätsplattform für das Industrielle Internet der Dinge (IIoT). Der RTI Connext® Datenbus ist ein Software-Framework, das Informationen in Echtzeit teilt und Applikationen als ein integriertes System zusammenarbeiten lässt. Es verbindet sich über Feld, Fog und Cloud. Seine Zuverlässigkeit, Security, Leistung und Skalierbarkeit haben sich bereits in den anspruchsvollsten industriellen Systemen bewiesen. Diese umfassen u. a. Medizintechnik, Automotive, Energie, Luft- und Raumfahrt, Industrieautomatisierung, Transport, SCADA, Marinesysteme sowie Wissenschaft und Forschung.
RTI zählt zu den innovativsten Anbietern von Produkten, die auf dem Data Distribution Service™ (DDS) der Object Management Group (OMG) basieren. Das privat geführte Unternehmen hat seinen Sitz in Sunnyvale, Kalifornien.

Firmenkontakt
Real-Time Innovations, Inc. (RTI)
Reiner Duwe
Terminalstr. Mitte 18
85356 München
+49 151 41460561
info@rti.com
http://www.rti.com

Pressekontakt
Agentur Lorenzoni GmbH, Public Relations
Beate Lorenzoni
Landshuter Straße 29
85435 Erding
+49 8122 559 17-0
rti@lorenzoni.de
http://www.lorenzoni.de

Gesundheit/Medizin

Rise In Investments To Develop New Nootropics Has Boosted The Brain Health Supplements

The rise in promotional activities by the producers of brain health supplements and willingness to accept such supplements among the general population has boosted the market for brain health supplements. Nootropics are the natural supplement or drug that can enhance cognition and memory and have constructive effects on brain function on healthy people. In addition, nootropics may help reduce age-related declines in brain function. The increased awareness regarding such benefits of nootropics and surge in a number of self-directed consumers have improved the growth of the brain health supplements.

The most popular brain health supplement is fish oil. Fish oil supplements are a prime source of eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), and two types of omega-3 fatty acids. Researchers believe that DHA plays an important role in maintaining the structure and function of the brain. In addition, DHA accounts for roughly 25 percent of the total fat, and 90 percent omega-3 fatty acids, which are found in brain cells. Therefore, taking DHA supplements are said to be linked with enhanced thinking skills, memory, and reaction times. However, EPA is not always related to improved brain function, people with depression tend to find consumption of EPA beneficial as it improves mood. Thus, fish oil is regarded as one of the best brain health supplements.

From decades caffeine is regarded as the best natural brain health supplement, which is found in coffee, tea, and dark chocolate. Caffeine stimulates the brain and central nervous system, which makes one feel less tired and more alert. Furthermore, several studies prove that caffeine can make a person more energized and improves memory as well as general brain function. However, consuming too much caffeine can lead to nausea, trouble sleeping, and anxiety. Another brain health supplement that is globally accepted is Ginkgo biloba. Ginkgo biloba is an herbal supplement obtained from its tree and extremely powerful brain health supplements that boost brain power. It is claimed that it increases blood flow to the brain, which improves focus and memory. There are studies that proved in middle-aged people Ginkgo biloba supplements improved memory and thinking skills. However, not all studies showed the same results.

The leading brain health supplements manufacturer company, Neurohacker Collective, recently decided to expand its product development team to meet the increasing demand for new formulations. The company intends to accelerate development significantly to launch new product over the next year. This move will enable the development of brain health supplements for healthy aging, sleep, pain, mood, and immune support. James Schmachtenberger, the CEO of the company, stated, “The Neurohacker product development philosophy is focused on the complex systems modeling necessary to deliver real efficacy at the scale in the nutraceutical space. In addition, our product development team consists of doctors, neuroscientists, and chemists, who have identified product opportunities where we can use our unique formulation process to deliver the best product in the market.”

Neurohacker Collective was founded in 2015 and since it has keen in creating best brain health supplements by employing a unique methodology to research and development. The rise in awareness regarding the brain health supplements and increasing investments by the market players has escalated the brain health supplements market. In a recent report on the brain health supplements, Allied Market Research analyzed the recent market trends and summarized that the market was valued at $3.1 billion in 2016, estimated to grow by a CAGR of 8.8% during the period 2017-2023. The report offers Porter’s five forces analysis, key segments and sub-segments, regions, drivers, restraints, and opportunities in the brain health supplements. Furthermore, it assesses key market players and the growth of the market in various regions including North America, LAMEA, Europe, and Asia-Pacific. The report is essential for market players, business experts, entry-level organizations to determine the market trends and strategies to boost revenue.

Source: https://www.alliedmarketresearch.com/brain-health-supplements-market 

Gesundheit/Medizin

Rotary Chair Gains Unique Presence in Vestibular Testing with its Unparalleled Analysis and Relative Affordability

Prevalence of vestibular disorders is highly perceptible worldwide, while associated with diagnosis and treatment procedures currently available are ineffective. Considerable interest has been observed in the development of novel ways for suspecting central and peripheral vestibular abnormalities. In addition to optimizing in treatment measures.

Vestibular testing market continues to develop new diagnostic approaches, which are superior to currently used tests. Fact.MR’s recently completed compiled study for the vestibular testing market at nearly 7% CAGR during the period of forecast, 2018 to 2028 . Psychophysical testing is also considered to be capable of providing insight into central and peripheral vestibular processing, thereby paving ways for the development of vestibular psychophysics as diagnostic tool.

Request For Sample Report – https://www.factmr.com/connectus/sample?flag=S&rep_id=1313

Videonystagmography (VNG) continues to prevail as sought-after vestibular testing method, in light of its capability to evaluate eye movements during multiple tasks, and aids the difference between right and left inner ear. Over-the-counter share of the vestibular testing market wants to be covered by VNG during the period of forecast.

Rotary chair, on the other hand, is gaining a unique presence in the vestibular testing market, on the back of unparalleled analysis offered by evaluation of both central and peripheral vestibular diseases. Future prospects of rotary chair will remain bullish, with more affordable advances in the area, such as booth-less rotary chair. VNG in the vestibular testing market, on the basis of revenue share, now becoming the new standard of the vestibular assessment.

Despite advances in the testing and documentation of pediatric vestibular deficits, challenges. Several children with the ailment are unable to pursue treatment, which in turn arrests the overall outcomes of pediatric vestibular disease. In a bid to resolve these difficulties, „educational organizations in collaboration with physical and occupational therapists are aiding integration of vestibular training in their activities ,“ says a lead analyst at Fact.MR.

To know the Latest Trends in Vestibular Testing Market, Visit – https://www.factmr.com/report/1313/vestibular-testing-market

The analyst also adds to that the activities that are involved in an imperative part of these programs. Well-structured vestibular rehabilitation therapy programs are provided by healthcare and educational institutions.

The Vestibular Disorders Association has estimated 100 Mn Americans to be affected by a vestibular ailment at some stage of their lives. In the US alone, over US $ 1 Bn is spent on medical care for patients with vestibular disorders. Availability of an effective vestibular testing procedure.

North America continues to be the largest market for vestibular testing in North America’s vestibular testing market. Newport-Mesa Audiology, Balance & Ear Institute are launching vestibular rehabilitation therapy programs, in a bid to spread awareness on the disease and available potential treatment procedures for resolving the same.

To Buy Vestibular Testing Market Report, Check the link https://www.factmr.com/checkout/1313/S

About Fact.MR

Fact.MR is a full-growing suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that’s why we publish multi-industry global, regional, and country-specific research reports.

Contact Us

Fact.MR

11140 Rockville Pike

Suite 400

Rockville, MD 20852

United States

Email: sales@factmr.com

Web: https://www.factmr.com/

Pressemitteilungen

Radiologie überwacht IHE Scheduled Workflow mit PRTG

ZENTRALES E-HEALTH-MONITORING MIT DICOM- UND HL7-SENSOREN

Radiologie überwacht IHE Scheduled Workflow mit PRTG

Nürnberg/Herford/Minden-Lübbecke, 28. August 2018 – Die langjährige Partnerschaft zwischen dem Netzwerk-Monitoring-Spezialisten Paessler und dem IT-Beratungsunternehmen neam IT Services GmbH zahlt sich für einen Kunden im Gesundheitswesen aus. Zusammen sorgen die Unternehmen für ein umfassendes Monitoring der medizinischen Infrastruktur in der Radiologie Herford sowie dem Mammographie Screeningzentrum Herford/Minden-Lübbecke. PRTG überwacht den Scheduled Workflow und trägt durch ein schnelles Troubleshooting dazu bei, Ausfallzeiten und Kosten zu minimieren.

Mehr als 200.000 Systemadministratoren vertrauen auf Paesslers PRTG Network Monitor, um Probleme in ihrer IT-Umgebung rechtzeitig zu erkennen. Die aktuelle PRTG-Version verfügt nun über DICOM- und HL7-Sensoren, mit denen das Tool auch die medizinische Infrastruktur in das zentrale Monitoring einbeziehen kann.

Monitoring kontrolliert IHE Scheduled Workflow
Nach der Neugründung der Radiologie Herford und der Vergrößerung des Mammographie Screeningzentrums Herford/Minden-Lübbecke war das Ziel, bekannte und immer wieder auftretende Probleme in Radiologie-Praxen von vornherein zu vermeiden. Mit PRTG Network Monitor hat die Praxis einen zentralen Überblick über ihre digitalisierte Medizintechnik und überwacht verschiedene Aspekte ihres IHE Scheduled Workflows. Dieser umfasst unter anderem die Beauftragung, Terminierung, Bilderstellung, -speicherung und -anzeige für radiologische Untersuchungen – wichtige Daten und Systeme, die für den Betrieb der Praxis unerlässlich sind.

„Unser Partner neam IT Services verfügt über eine tiefe Fachkenntnis und konnte unsere Lösung daher erfolgreich in die Infrastruktur der Radiologie integrieren“, sagt Sebastian Kruger, Partner Account Manager der Paessler AG. Nach der Implementierung konnten Probleme und Ausfälle innerhalb des Workflows über PRTG schnell festgestellt und behoben werden. „Über unser automatisiertes Frühwarnsystem wird neam bei Störungen alarmiert. So kann unser Partner proaktiv mit der Problemlösung beginnen, noch bevor der Kunde die Störung im Arbeitsalltag überhaupt bemerkt.“

Hochauflösendes Bildmaterial kann unter paessler@sprengel-pr.com angefordert werden.

neam IT-Services GmbH
T: +49 5251 1652-0
vertrieb@neam.de
www.neam.de

Über Paessler AG
PRTG Network Monitor von Paessler ist eine preisgekrönte Lösung für leistungsfähiges, bezahlbares und benutzerfreundliches Unified Monitoring. Die flexible Software eignet sich ideal, um komplette IT-Infrastrukturen im Blick zu behalten. PRTG sorgt in Unternehmen und Organisationen aller Größen und Branchen für Ruhe und Sicherheit. Aktuell vertrauen über 200.000 IT-Administratoren in mehr als 170 Ländern auf die Software der Paessler AG. Das 1997 in Nürnberg gegründete Unternehmen wird bis heute privat geführt und ist sowohl Mitglied des Cisco Solution Partner Program als auch ein NetApp Alliance Partner und VMware Technology Alliance Partner. Erfahren Sie mehr über Paessler und PRTG unter www.paessler.de

Firmenkontakt
Paessler AG
Sarolta Hershey
Thurn-und-Taxis-Str. 14
90411 Nürnberg
+49 (0)911 93775-0
press@paessler.com
http://www.de.paessler.com

Pressekontakt
Sprengel & Partner GmbH
Samira Liebscher
Nisterstrasse 3
56472 Nisterau
02661-912600
paessler@sprengel-pr.com
http://www.sprengel-pr.com

Pressemitteilungen

Global Wound Irrigation Solution Market: North America Estimated to Dominate the Market with a Revenue Share of 39.0% in 2018

According to the latest market report published by Fact MR, titled ‘Global Wound Irrigation Solution Market: Forecast, Trend Analysis & Competition Tracking – Global Review: 2018- 2028’, the global wound irrigation solution market is expected to expand at a significant CAGR during the forecast period 2018–2028.

The wound irrigation solution market is segmented based on product type, end user and region. On the basis of product type, the wound irrigation solution market has been segmented into two segments such as wetting agents and antiseptics. The antiseptics segment of wound irrigation solution market is expected to be the fast-growing segment over the forecast period, registering a significant CAGR in terms of growth, whereas wetting agents segment is expected to maintain dominance in terms of revenue in the wound irrigation solution market. The increasing demand for advanced wound care solution owing to the growing number of chronic wounds worldwide is expected to boost the growth of the wound irrigation solution market over the forecast period.

Request For Report Sample- https://www.factmr.com/connectus/sample?flag=S&rep_id=1166

The wetting agents segment dominated the wound irrigation solution market with significant a market value in 2017. Also, the segment is expected to maintain its dominance in the wound irrigation solution market with a significant value by 2028 end.

On the basis of end users, the wound irrigation solution market has been segmented into hospitals, ambulatory surgical centers, clinics, long term care centers and home care settings.

On the basis of region, the wound irrigation solution market has been segmented into North America, Latin America, Western Europe, Eastern Europe, Asia Pacific Excluding Japan (APEJ), Japan and the Middle East and Africa (MEA).

Increasing prevalence of acute and chronic wounds coupled with increasing adoption of wound irrigation solution in wound care is expected to boost the growth of the wound irrigation solution market over the forecast period. With increasing prevalence of chronic and acute wounds, several healthcare facilities are focusing on implementing educational programs to raise awareness regarding benefits of wound irrigation solution, including the mandatory use of wound irrigation solution before the dressing of a wound. Increasing preference of wound irrigation solution on the account of their high specificity and efficacy in cleaning and healing of wounds with strong presence of distribution channel is further expected to drive the growth of the wound irrigation solution market over the forecast period. Rising aging population with diabetes causing pressure ulcer, increasing adoption of advance wound care products and growing acceptance of standardized protocols to manage complex wounds are also expected to drive the growth of the wound irrigation solution market over the forecast period. Growing focus of leading wound irrigation solution manufacturers on emerging economies such as India and China is estimated to have a positive impact on the wound irrigation solution market in Asia-Pacific. However, innovating the wound irrigation solutions by enhancing their ability to retain moisture balance and ingraining extended oxygen permeability and antimicrobial activity along with availability of expanded product line for wound care are factors also expected to drive the growth of the wound irrigation solution market in North America and Europe over the forecast period.

However, limited awareness about available treatment options among general population, lack of reimbursement and higher demand for low frequency dressing change in acute care settings are factors that may hamper the demand for wound irrigation solution and restrain the growth of wound irrigation solution market over the forecast period.

To know more about Wound Irrigation Solution Market Trends, check the link –https://www.factmr.com/report/1166/wound-irrigation-solution-market

This report assesses trends driving the growth of segmental wound irrigation solution markets and offers analysis and insights into the regional wound irrigation solution market. North America is estimated to dominate the wound irrigation solution market with a maximum value share by the end of 2018.

Examples of some the key wound irrigation solution market companies covered in this report include Schulke & Mayr, Reckitt Benckiser Group plc., B. Braun Melsungen AG, ConvaTec Group plc., Anacapa Technologies, Becton, Dickinson and Company, Coloplast A/S, 3M Company, SteadMed Medical and Integra Life Sciences Corporation. These leading players focus on to consolidate their position in the global wound irrigation solution market by actively participating in activities such as partnerships, mergers, acquisitions and collaborations.

The global wound irrigation solution market is segmented as follows:

By Product Type

  • Wetting agents
  • Antiseptics

By End User

  • Hospitals
  • Ambulatory Surgical Centers
  • Clinics
  • Long Term Care Centers
  • Home Care Settings

By Region

  • North America (U.S., Canada)
  • Latin America (Mexico, Brazil, Argentina, Chile, Peru)
  • Western Europe (Germany, Italy, France, U.K, Spain, BENELUX, Nordic, Eastern Europe)
  • CIS and Russia
  • Asia-Pacific (China, India, ASEAN, South Korea)
  • Japan
  • Middle East and Africa (GCC Countries, South Africa, Turkey, Iran, Israel)

About Fact.MR

Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that’s why we publish multi-industry global, regional, and country-specific research reports.

Contact Us

Fact.MR

11140 Rockville Pike

Suite 400

Rockville, MD 20852

United States

Email: sales@factmr.com

Web: https://www.factmr.com/

Gesundheit/Medizin

Orthopedic Implants Market: Sales in Knee Reconstruction Pre-eminent, Hip Reconstruction to Gain Steady Momentum, slates Fact.MR

The orthopedic implants market continues to be an avenue in the global medical technology space. Emergence of advanced technologies coupled with rise in orthopedic disorders are major growth determinants for the orthopedic implants market. A recent report by Fact.MR envisions the orthopedic implants market to record on august 6.5% CAGR over the forecast period 2018 to 2027 . In practice, orthopedic surgeries are used in the field of orthopedic surgeries.

Orthopedic implants market, trailed by hip reconstruction. Governments across the globe are looking for ways to reduce orthopedic implants used in knee reconstruction surgeries. For example, the National Pharmaceutical Pricing Authority (NPPA) has announced price caps on the orthopedic implants employed in knee reconstruction surgeries, bringing the basic models down to 65%.

Request For Report Sample – https://www.factmr.com/connectus/sample?flag=S&rep_id=990

Additionally, the NPPA has also passed off most of the margins in trade, thereby alleviating the impact of the orthopedic implants‘ reduced prices on research & innovation. Search efforts from the government will further underpin the growth of the orthopedic implants market in the near future. Orthopedic implant sales for knee reconstruction are envisaged to increase at 6.3% CAGR through 2027 , according to Fact.MR study. In case of hip reconstruction surgeries, the dislocation of orthopedic implants has prevailed as a prominent concern among patients and healthcare professionals alike.

A recent study carried out by a Well-Known Research Director, Geoffrey Westrich, has published a paper entitled „Dual Mobility,“ with zero dislocation tendency in hip reconstruction and replacement. Researchers have found out about dual-mobility orthopedic implants to have no dislocations post three-year follow-up of patients.

Results of the study are considered to be encouraging, high demand for orthopedic implants among patients, and are likely to lessen concerns. Search novel revelations and discoveries will continue to propel demand for orthopedic implants associated with hip reconstruction. Revenues from sales of orthopedic implants for hip reconstructed exceeded US $ 16,800 Mn in 2017.

North America’s preeminent orthopedic implants market will continue to prevail, states Fact.MR study. According to the American Joint Replacement Registry (AJRR), over 7 million have been collectively linked to knee and hip surgeries. Over half revenue share of the market wants to be accounted for by orthopedic implants sales in North America by 2027-end.

To know the Latest Trends in Orthopedic Implants Market, visit – https://www.factmr.com/report/990/orthopedic-implants-market

The US Food and Drug Administration (FDA) has approved the Surgical System as the first one. More companies have been investing in the technology for providing a better navigation during the procedure, and obtaining 3D scans to aid designing of customized joints.

Acquisitions and mergers continue to be key strategic expansion methods adopted by companies operating in the orthopedic implants market. Acquisition of Mako Surgical Corp. by Stryker – for total hip and knee construction robotic products for orthopedic implants, and Blue Belt Holdings by Smith & Nephew for robotic-assisted orthopedic implant surgery are often used for such strategic expansions.

Continues advancements in orthopedics have resulted in the development of new, novel implants, with several of them being used in clinical practice with none or little evidence of their effectiveness and safety. Appropriate staging of new orthopedic implants implementation is therefore gaining importance in the market, to eliminate relevant adverse effects on patients. Methodologies for evaluation of new orthopedic implants are now used as a basis for contemplating their success and resolving observed drawbacks.

To Buy Orthopedic Implants Market Report, Check the page- https://www.factmr.com/checkout/990/S

 About Fact.MR

Fact.MR is a full-growing suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that’s why we publish multi-industry global, regional, and country-specific research reports.

Contact Us

Rohit Bhisey

Fact.MR

11140 Rockville Pike

Suite 400

Rockville, MD 20852

United States

Email: sales@factmr.com

Web: https://www.factmr.com/

Pressemitteilungen

Coverageaufnahme Aladdin Blockchain Technologies Holding SE

Disruptives Potential im Healthcare-Markt

Coverageaufnahme Aladdin Blockchain Technologies Holding SE

AlsterResearch hat das Coverage der Aktie der Aladdin Blockchain Technologies Holding SE aufgenommen.

Das Unternehmen agiert als Holding des Aladdin Unternehmensverbunds. Ziel ist die Schaffung eines Ökosystems zur Verwaltung und Verarbeitung medizinischer Daten durch Einbeziehung modernster Blockchain-, Big Data- und KI-Technologien. Die Gesellschaft strebt an, sich als globaler Player zu etablieren. Der Hauptfokus liegt dabei zunächst auf den stark wachsenden Gesundheitsmärkten Chinas und Indiens, sukzessiv sollen weitere bevölkerungsreiche und wachstumsstarke Länder Asiens erschlossen werden.

Aladdin setzt bei seiner proprietären Technologie auf eine fortschrittliche Blockchain-Architektur mit Smart Contracts zur verteilten Speicherung von Transaktionen in Kombination mit einer intelligenten Big Data-Plattform.Integrierte KI-Technologien ermöglichen weitere Anwendungen, wie Diagnoseunterstützung, Risikoscreening oder Marktanalysen.

Die Gesellschaft setzt zum Markteintritt auf Kooperationen mit Gesundheitsdienstleistern, Institutionen (z.B. dem chinesischen Gesundheitsministerium) und lokalen Partnern um möglichst zahlreiche Quellen für den Aufbau eines umfassenden medizinischen Datenspeichers auszuschöpfen. Aktuell erfolgt in der laufenden Phase 1 die Einspeisung von einer Million Patientenakten in eine Secure Cloud durch ein Joint-Venture mit einem lokalen Krankenhausbetreiber in Peking.Gleichzeitig entsteht derzeit der erste Prototyp einer KI-Applikation zur Netzhautdiagnostik von Diabetes. Der Start eines Gesundheits-Marktplatzes ist im Verlauf des späten zweiten Halbjahrs geplant.

Aladdin kann auf ein erfahrenes Management-Team zurückgreifen.CEO Menpes-Smith und COO Shah verfügen über Erfahrungen aus zahlreichen Unternehmensgründungen im Tech-Bereich, vor allem im asiatischen Raum. Technologische Kompetenz im Design und Einsatz von Blockchain-Technologien bringen die mit dem Partner Elemental Concept verbundenen, renommierten Entwickler mit.

AlsterResearch sieht die Plausibilität und eine hohe Skalierbarkeit des Geschäftsmodells. Im Gegensatz zur Unternehmensführung skizziert das Researchhaus einen etwas weniger ambitionierten, wenn auch immer noch dynamischen Wachstumspfad. Risiken werden sowohl in zeitlicher Hinsicht (Projektverzögerungen) als auch technologischer Art gesehen.

Aufgrund der noch frühen Unternehmensphase sieht AlsterResearch eine Vielzahl von Chancen und Risiken. Noch ist die Visibilität zu gering, um eine fundierte und valide Unternehmensbewertung zu erstellen. Aus diesem Grund vergeben die Hamburger Analysten bei ihrer Ersteinschätzung kein Kursziel und kein Anlageurteil.

Aktuell notiert die Aktie der Gesellschaft im Primärmarkt der Börse Düsseldorf. Im September will das Unternehmen ein Wertpapierprospekt veröffentlichen und anschließend in ein höheres Marktsegment wechseln. In Q4 soll zur weiteren Wachstumsfinanzierung eine Kapitalerhöhung stattfinden.

Das vollständige Research finden Sie unter www.alsterresearch.com.

AlsterResearch konzentriert sich auf Equity Research. Aktuell covern wir mehr als 70 verschiedene Aktien, den Großteil als Partner in einem Research Joint-Venture mit der Norddeutschen Landesbank. Das gemeinsame Portfolio umfasst mehr als 200 deutsche und internationale Werte.
Zusätzlich verhelfen wir kleineren Unternehmen zu einer verbesserten Wahrnehmung am Kapitalmarkt und suchen für „unseren Kreis“ institutioneller Investoren kontinuierlich nach spannenden und erfolgversprechenden Investitionsmöglichkeiten.

Kontakt
SRH AlsterResearch AG
Andreas Schüler
Leinpfad 100
22299 Hamburg
+494030929352
+49 40 556 330-54
a.schueler@alsterresearch.com
http://www.alsterresearch.com